Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Katharine E. Spink currently holds 10,949 shares of Asterias Biotherapeutics, Inc. (AST), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Katharine E. Spink has been a net seller of AST stock. They have purchased $0 and sold $337.6K worth of shares.
Katharine E. Spink's most recent insider trade was on Jun 5, 2017, when they sold 7,260 shares at $3.20 per share.
Katharine E. Spink serves as Executive at Asterias Biotherapeutics, Inc. (AST). They have executed 34 insider transactions totaling $337.6K over their tenure at the company.
Katharine E. Spink holds the position of Executive at Asterias Biotherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Katharine E. Spink has shown a selling trading pattern, with $0 in total purchases and $337.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Katharine E. Spink was on Jun 14, 2011, when they sold $96.7K worth of GERN shares. This transaction involved 22,591 shares at $4.28 per share.
Katharine E. Spink currently owns 10,949 shares of Asterias Biotherapeutics, Inc. (AST), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Katharine E. Spink's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Katharine E. Spink has 34 Form 4 filings on record as an insider at Asterias Biotherapeutics, Inc..
Set alerts for Katharine E. Spink and 40,000+ other insiders.